News for 'SARS'

SARS hits grey PC market

SARS hits grey PC market

Rediff.com5 May 2003

Future Covid waves unlikely to have serious impact in India: Experts

Future Covid waves unlikely to have serious impact in India: Experts

Rediff.com20 Mar 2022

The reason is that because of the hybrid immunity after three waves of natural infection and a large proportion of adults receiving both doses of COVID-19 vaccine, the susceptible pool has come down drastically, Lahariya said.

Covid 3rd wave unlikely to be as severe as second: Study

Covid 3rd wave unlikely to be as severe as second: Study

Rediff.com25 Jun 2021

A third wave of COVID-19 -- if it occurs -- is unlikely to be as severe as the second wave given the extent of spread of coronavirus infections that has already taken place in the country, according to a study.

New Covid XE variant not more severe than Omicron: Dr Kang of CMC Vellore

New Covid XE variant not more severe than Omicron: Dr Kang of CMC Vellore

Rediff.com8 Apr 2022

The World Health Organisation has issued warning against XE, a new variant of Omicron first detected in the UK.

Covaxin shows 78% efficacy in phase-3 interim analysis

Covaxin shows 78% efficacy in phase-3 interim analysis

Rediff.com21 Apr 2021

Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication.

Covid vax don't give total protection: WHO scientist

Covid vax don't give total protection: WHO scientist

Rediff.com12 Aug 2021

"Even though the vaccine may not be able to provide absolute protection against different variants of virus, it can certainly reduce the risk of death and complications," a statement quoting WHO chief scientist Soumya Swaminathan said.

New Covid lineage identified, 2nd in India after 'double mutant' virus

New Covid lineage identified, 2nd in India after 'double mutant' virus

Rediff.com22 Apr 2021

The new lineage called B.1.618 is distinct from the B.1.617, also known as the 'double mutant' virus that contains two mutations, E484Q and L245R, and is believed to be behind the powerful second COVID-19 wave sweeping through India.

SAR Geelani's CRPP a Maoist front: Government

SAR Geelani's CRPP a Maoist front: Government

Rediff.com7 Dec 2011

The reference to CRPP as a Maoist front organisation came in a written reply in Rajya Sabha by Jitendra Singh, Minister of State for Home Affairs.

Report indicates Wuhan scientists got sick with Covid before outbreak

Report indicates Wuhan scientists got sick with Covid before outbreak

Rediff.com24 May 2021

Three researchers from the Wuhan Institute of Virology sought hospital care in November 2019, weeks before Beijing disclosed the COVID-19 pandemic, a United States media report said, citing a previously undisclosed American intelligence document that could add weight to growing calls for a full scale probe of whether the coronavirus may have escaped from China's top bio lab.

Covid: PM chairs high-level meet, stresses on oxygen availability

Covid: PM chairs high-level meet, stresses on oxygen availability

Rediff.com11 Sep 2021

Modi stressed on the need for constant genome sequencing to monitor emergence of mutants and also to ensure increased oxygen availability, the Prime Minister's Office (PMO) said in a statement.

COVID-19: 'We will be dealing with it for 2 years at least'

COVID-19: 'We will be dealing with it for 2 years at least'

Rediff.com29 Oct 2020

'The most intriguing thing (about COVID-19) is the range of the illness -- from asymptomatic or less symptoms to death and quite severe manifestations.' 'The vaccine will be at least another year away from having any effect.'

5 Lata Mangeshkar-R D Burman Gems

5 Lata Mangeshkar-R D Burman Gems

Rediff.com27 Jun 2022

Rahul Dev Burman's collaboration with Asha Bhosle and Kishore Kumar was unique, but he saved his best for Lata Mangeshkar.

'Strong evidence' COVID-19 predominantly spreads through air: Study

'Strong evidence' COVID-19 predominantly spreads through air: Study

Rediff.com16 Apr 2021

The researchers noted that transmission rates of SARS-CoV-2 are much higher indoors than outdoors, and transmission is greatly reduced by indoor ventilation.

Centre studies if coronavirus present in Ganga water

Centre studies if coronavirus present in Ganga water

Rediff.com8 Jun 2021

The Centre is conducting a study to assess the presence of SARS-CoV-2, or novel coronavirus, in the Ganga as corpses were found dumped in the river during the second Covid wave, and were fished out from districts in Uttar Pradesh and Bihar, officials said.

Zydus's India-made Covid vaccine gets emergency use approval

Zydus's India-made Covid vaccine gets emergency use approval

Rediff.com20 Aug 2021

This is the world's first DNA-based vaccine against the coronavirus, and this three-dose vaccine when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance

Omicron in community transmission stage in India: INSACOG

Omicron in community transmission stage in India: INSACOG

Rediff.com23 Jan 2022

The Omicron variant of COVID-19 is in the community transmission stage in India and it has also become dominant in multiple metros, where new cases have been rising exponentially, said Indian SARS-CoV-2 Genomics Consortium.

Scientists break 'camouflage' of novel coronavirus

Scientists break 'camouflage' of novel coronavirus

Rediff.com26 Jul 2020

The researchers from the the University of Texas Health Science Center at San Antonio (UT Health San Antonio) in the United States said by enabling this modification, nsp10 protects the virus from host cell immune response.

New Covid strain: Total 25 people in India test positive

New Covid strain: Total 25 people in India test positive

Rediff.com31 Dec 2020

These 25 people include the 20 who were found positive with the mutated strain on Tuesday and Wednesday.

Very low risk to newborns from Covid +ve moms: Study

Very low risk to newborns from Covid +ve moms: Study

Rediff.com13 Oct 2020

To reduce the risk of transmitting the SARS-CoV-2 virus to newborns after delivery, the researchers said the hospital staff practised social distancing, wore masks, and placed COVID-positive moms in private rooms.

Self-use Covid-19 testing kits to be available at stores for Rs 250

Self-use Covid-19 testing kits to be available at stores for Rs 250

Rediff.com21 May 2021

Pune's Mylab Discovery Solutions' CoviSelf, which gives results in 15 minutes, gets ICMR nod

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

Rediff.com17 May 2021

This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.

'All the vaccines, so far, seem to be protecting from severe illness'

'All the vaccines, so far, seem to be protecting from severe illness'

Rediff.com9 Nov 2021

'The immune protection may well wane somewhat, and that's what we have to monitor.' 'Should it wane to the point where vaccinated individuals are getting severe disease, then we really will need to give them booster shots and that'll apply regardless of what vaccine they've got the first time.'

Gujarat Omicron patient's kin also test positive for the same

Gujarat Omicron patient's kin also test positive for the same

Rediff.com10 Dec 2021

The wife and brother-in-law of an NRI man, who had been found infected with the Omicron variant of COVID-19 here in Gujarat a week back, were also detected with the new strain, officials of the Jamnagar Municipal Corporation (JMC) said on Friday.

Molnupiravir not to be included in Covid treatment now

Molnupiravir not to be included in Covid treatment now

Rediff.com11 Jan 2022

The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now, official sources said on Tuesday.

Covid's rate of spread drops, but not in 4 cities

Covid's rate of spread drops, but not in 4 cities

Rediff.com21 Sep 2021

However, the R-values of major cities, Mumbai, Kolkata, Chennai, Bengaluru, are over 1.

Kids unlikely to get disproportionately hit by 3rd wave: Study

Kids unlikely to get disproportionately hit by 3rd wave: Study

Rediff.com17 Jun 2021

The SARS-CoV-2 sero-positivity rate among children is high and comparable to the adult population and hence, it is unlikely that any future third wave of the prevailing COVID-19 variant would disproportionately affect children aged two years and above, according to the interim findings of an ongoing study conducted in the country.

ICMR revises advisory on use of hydroxychloroquine

ICMR revises advisory on use of hydroxychloroquine

Rediff.com23 May 2020

Three new categories -- all asymptomatic healthcare workers working in non-COVID hospitals/areas of COVID hospitals/blocks, asymptomatic frontline workers such as surveillance workers deployed in containment zones and paramilitary/police personnel involved in COVID-19 related activities -- have now been included.

Centre issues alert to states over Tomato Flu in children

Centre issues alert to states over Tomato Flu in children

Rediff.com24 Aug 2022

Centre has sent an advisory to states on HFMD (Hand Foot and Mouth Disease), commonly known as Tomato Flu, stating that it's a self-limiting illness targeting mostly young children aged 1-10 years and immune-compromised adults and no specific drug exists to treat it.

'We can't get rid of COVID-19 for a long time to come'

'We can't get rid of COVID-19 for a long time to come'

Rediff.com10 Jun 2022

'There will be ups and downs, and we have to plan how we live with it now.'

Watching global Covid spread, IIT-Kanpur has not predicted 4th wave: Govt

Watching global Covid spread, IIT-Kanpur has not predicted 4th wave: Govt

Rediff.com22 Mar 2022

Noting that various mathematical models meant for predicting coronavirus waves have repeatedly failed to give reliable results due to a small sample size, the Centre on Tuesday said it is closely following the virus trajectory globally, given the emergence of its new variants.

'No need to give special attention to COVID-19 anymore'

'No need to give special attention to COVID-19 anymore'

Rediff.com22 Aug 2022

'All actions for COVID-19 should be the same as for other routine health conditions.' 'There is no need to report the matter in the media all the time; not on front page please.'

Centre's Omicron FAQ says mutations may lessen vaccine efficacy

Centre's Omicron FAQ says mutations may lessen vaccine efficacy

Rediff.com3 Dec 2021

The Union health ministry on Friday said while there is no evidence to suggest that existing vaccines do not work on the Omicron variant of SARS-CoV-2, some of the mutations reported may decrease the efficacy of the jabs.

Oxford, AstraZeneca COVID-19 vaccine trials resume in UK

Oxford, AstraZeneca COVID-19 vaccine trials resume in UK

Rediff.com12 Sep 2020

AstraZeneca and the University of Oxford, as the trial sponsor, said that they cannot disclose further medical information but confirmed that independent investigations concluded that the trials were safe to restart.

New Covid variant yet to be detected in India, say officials

New Covid variant yet to be detected in India, say officials

Rediff.com26 Nov 2021

The Indian SARS-CoV-2 Genomics Consortium is closely tracking the new variant of COVID-19 called B.1.1.529 and its presence has not been detected in the country yet, officials said on Friday.

India had 64 lakh COVID-19 infections by May: National serosurvey

India had 64 lakh COVID-19 infections by May: National serosurvey

Rediff.com11 Sep 2020

Seropositivity was the highest in the age group of 18-45 years (43.3 per cent), followed by those between 46-60 years (39.5 per cent) and it was the lowest among those aged above 60 (17.2 per cent).

'Omicron may make you more sick'

'Omicron may make you more sick'

Rediff.com29 Nov 2021

'This virus may have more immune evasion capability and therefore, it may make you more sick.'

Barge tragedy: 66 dead; Navy deploys diving teams to look for bodies

Barge tragedy: 66 dead; Navy deploys diving teams to look for bodies

Rediff.com28 May 2021

The Navy and the Coast Guard continued the search for the nine missing personnel from the barge and 11 from Varaprada even as hopes of finding more survivors of the Cyclone Tauktae fury receded, an official said.

US allows 'game-changer' saliva-based Covid test

US allows 'game-changer' saliva-based Covid test

Rediff.com16 Aug 2020

The new test it will enable rapid testing amongst more people easily.

Govt panel recommends regular market approval for Covishield, Covaxin

Govt panel recommends regular market approval for Covishield, Covaxin

Rediff.com20 Jan 2022

An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to COVID vaccines Covishield and Covaxin for use in adult population subject to certain conditions, official sources said.